Connect Biopharma Holdings Limited Federal Income Tax Expense (Benefit), Continuing Operations
Connect Biopharma Holdings Limited (CNTB) reported Federal Income Tax Expense (Benefit), Continuing Operations of $200.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations · last filed 2025-03-31
- Connect Biopharma Holdings Limited federal income tax expense (benefit), continuing operations for fiscal 2024 was $200.00K, a 100.00% increase from fiscal 2023.
- Connect Biopharma Holdings Limited federal income tax expense (benefit), continuing operations for fiscal 2023 was $100.00K.
| Period end | Federal Income Tax Expense (Benefit), Continuing Operations 12 month |
|---|---|
| 2024-12-31 | $200.00K 10-K · filed 2025-03-31 |
| 2023-12-31 | $100.00K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |